135 related articles for article (PubMed ID: 37690231)
1. Inhibition of influenza a virus infection by natural stilbene piceatannol targeting virus hemagglutinin.
Huang L; Wang J; Ma X; Sun L; Hao C; Wang W
Phytomedicine; 2023 Nov; 120():155058. PubMed ID: 37690231
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment.
Yang X; Sun H; Zhang Z; Ou W; Xu F; Luo L; Liu Y; Chen W; Chen J
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902398
[TBL] [Abstract][Full Text] [Related]
3. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Effect of Isoquercitrin against Influenza A Viral Infection via Modulating Hemagglutinin and Neuraminidase.
Cho WK; Lee MM; Ma JY
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361900
[TBL] [Abstract][Full Text] [Related]
5. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin.
Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S
Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526
[TBL] [Abstract][Full Text] [Related]
6. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
[TBL] [Abstract][Full Text] [Related]
7. Artesunate inhibits PDE4 leading to intracellular cAMP accumulation, reduced ERK/MAPK signaling, and blockade of influenza A virus vRNP nuclear export.
Yang X; Long F; Jia W; Zhang M; Su G; Liao M; Zeng Z; Chen W; Chen J
Antiviral Res; 2023 Jul; 215():105635. PubMed ID: 37192683
[TBL] [Abstract][Full Text] [Related]
8. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
9. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.
Sakai K; Ami Y; Tahara M; Kubota T; Anraku M; Abe M; Nakajima N; Sekizuka T; Shirato K; Suzaki Y; Ainai A; Nakatsu Y; Kanou K; Nakamura K; Suzuki T; Komase K; Nobusawa E; Maenaka K; Kuroda M; Hasegawa H; Kawaoka Y; Tashiro M; Takeda M
J Virol; 2014 May; 88(10):5608-16. PubMed ID: 24600012
[TBL] [Abstract][Full Text] [Related]
10. Virus-neutralizing antibody response of mice to consecutive infection with human and avian influenza A viruses.
Janulíková J; Stropkovská A; Bobišová Z; Košík I; Mucha V; Kostolanský F; Varečková E
Acta Virol; 2015 Jun; 59(2):166-73. PubMed ID: 26104333
[TBL] [Abstract][Full Text] [Related]
11. Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.
Bestle D; Limburg H; Kruhl D; Harbig A; Stein DA; Moulton H; Matrosovich M; Abdelwhab EM; Stech J; Böttcher-Friebertshäuser E
J Virol; 2021 Sep; 95(20):e0090621. PubMed ID: 34319155
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
[TBL] [Abstract][Full Text] [Related]
13. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
[TBL] [Abstract][Full Text] [Related]
14. Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice.
Son S; Ahn SB; Kim G; Jang Y; Ko C; Kim M; Kim SJ
Antiviral Res; 2023 May; 213():105591. PubMed ID: 37003306
[TBL] [Abstract][Full Text] [Related]
15. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA #61 exerts a broad anti-influenza a virus effect by its long arm rings.
Hu J; Zhang L; Zheng X; Wang G; Chen X; Hu Z; Chen Y; Wang X; Gu M; Hu S; Liu X; Jiao X; Peng D; Liu X
Antiviral Res; 2023 Jul; 215():105637. PubMed ID: 37196902
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel penindolone derivatives as potential inhibitors of hemagglutinin-mediated membrane fusion.
Li B; Huang L; Lin J; Ma X; Luo Y; Gai W; Xie Y; Zhu T; Wang W; Li D
Eur J Med Chem; 2023 Oct; 258():115615. PubMed ID: 37413878
[TBL] [Abstract][Full Text] [Related]
18. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
19. Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle.
Hegazy A; Soltane R; Alasiri A; Mostafa I; Metwaly AM; Eissa IH; Mahmoud SH; Allayeh AK; Shama NMA; Khalil AA; Barre RS; El-Shazly AM; Ali MA; Martinez-Sobrido L; Mostafa A
BMC Complement Med Ther; 2024 Jan; 24(1):49. PubMed ID: 38254071
[TBL] [Abstract][Full Text] [Related]
20. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
